Litigation Details for Rochester Drug Co-Operative, Inc. v. Allergan plc (D. Mass. 2016)
✉ Email this page to a colleague
Rochester Drug Co-Operative, Inc. v. Allergan plc (D. Mass. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-08-26 |
Court | District Court, D. Massachusetts | Date Terminated | 2019-09-05 |
Cause | 15:1 Antitrust Litigation | Assigned To | Denise Jefferson Casper |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,649,180; 6,893,662; 8,580,302 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Rochester Drug Co-Operative, Inc. v. Allergan plc
Details for Rochester Drug Co-Operative, Inc. v. Allergan plc (D. Mass. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-06-29 | 1 | on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…“the ’170 patent”) and 5,541,171 (“the ’171 patent”). Both patents expired July 30, 2013. 83.…would push Asacol (400mg) over the “patent cliff” (i.e., upon patent expiry in July 2013, Warner Chilcott…suit alleging patent infringement. Warner Chilcott did this by listing the capsule patent in the FDA’s…of the capsule patent. 12. Warner Chilcott’s listing of the capsule patent in the Orange Book | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |